首页 › 基金 › TIMUCUAN ASSET MANAGEMENT INC/FL › GILD

TIMUCUAN ASSET MANAGEMENT INC/FL 对 GILD 的持仓历史

GILEAD SCIENCES INC · 医疗保健

TIMUCUAN ASSET MANAGEMENT INC/FL 在 Q3 2026 的 13F 申报中披露持有 GILD(GILEAD SCIENCES INC)1,400 股,市值约 US$209K,约占其申报组合的 0.01%,在其申报持仓中市值排名第 28 位。 TIMUCUAN ASSET MANAGEMENT INC/FL 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)1.40K 股
申报持仓市值$208.67K
组合权重0.01%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

TIMUCUAN ASSET MANAGEMENT INC/FL 对 GILD 的持仓演变

TIMUCUAN ASSET MANAGEMENT INC/FL 于 Q3 2026 首次披露 GILD 持仓:1,400 股(约 US$209K)。

逐季持仓明细

季度股数金额变化
Q3 2026 1.40K $208.67K 新进

关于 GILD 与 13F 数据

GILD(GILEAD SCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 34 只申报持有 GILD,申报仓位最大的包括:富达投资(FMR) (US$8.68B), 景顺 (US$5.76B), Capital World Investors (US$5.36B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 GILD 的基金

查看 GILD 的全部基金持有人 →

常见问题

How long has TIMUCUAN ASSET MANAGEMENT INC/FL held GILD?

TIMUCUAN ASSET MANAGEMENT INC/FL has disclosed GILD holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is TIMUCUAN ASSET MANAGEMENT INC/FL's current position in GILD?

As of Q3 2026, TIMUCUAN ASSET MANAGEMENT INC/FL holds 1.40K shares of GILD (GILEAD SCIENCES INC), valued at $208.67K, representing 0.01% of its reported portfolio and ranking #28.

Has TIMUCUAN ASSET MANAGEMENT INC/FL been buying or selling GILD?

In the latest 13F filing (Q3 2026), TIMUCUAN ASSET MANAGEMENT INC/FL newly opened its position in GILD.

Which other funds hold GILD?

Other major institutional holders of GILD include 富达投资(FMR), 景顺, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.